Industry

Cutera, Inc. Announces Pricing of Offering of $200 Million and Concurrent Private Placement of $10 Million of Convertible Senior Notes

BRISBANE, Calif.–(BUSINESS WIRE)–Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announced the pricing of $210 million aggregate principal amount of 2.25% convertible senior notes due 2028 (the “notes”) in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of … [Read more…]

First Guardant Health Liquid Biopsy Testing Service in Europe Now Operational at Vall d’Hebron Institute of Oncology

Barcelona-based testing service will advance cancer research and enable clinicians to personalize treatments more accurately and quickly for patients with late-stage cancer PALO ALTO, Calif. & BARCELONA, Spain–(BUSINESS WIRE)–Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and the Vall d’Hebron Institute of Oncology (VHIO), one of Europe’s leading cancer research organizations, today announced … [Read more…]

Pfizer Launches ‘An Accord for a Healthier World’ to Improve Health Equity for 1.2 Billion People Living in 45 Lower-Income Countries

Pfizer will provide all its current and future patent-protected medicines and vaccines available in the U.S. or EU on a not-for-profit basis to 45 lower-income countries. Rwanda, Ghana, Malawi, Senegal and Uganda are the first five countries to commit to join the Accord. Health officials in these countries will help identify and resolve hurdles beyond … [Read more…]

Faber-Castell and EnChroma make Father’s Day colourful

STEIN, Germany & BERKELEY, Calif.–(BUSINESS WIRE)–#colorishere—EnChroma, creators of glasses for the colourblind, is partnering with Faber-Castell to launch a video campaign that recognises and celebrates all colourblind fathers on Father’s Day. An estimated 350 million people worldwide are affected by colour blindness. One in 200 women and one in 12 men (8%) suffer from colour … [Read more…]

Genexine Appoints Industry Veteran Neil Warma as Chief Executive Officer to Accelerate Global Growth, Product Commercialization and Innovation

– Genexine to focus on global drug development and commercialization – Near term milestones should drive shareholder value – Renewed effort to expand pipeline with an emphasis on novel, differentiated products SEOUL, South Korea–(BUSINESS WIRE)–Genexine (KOSDAQ: 095700) a publicly traded, clinical stage biopharmaceutical company committed to the discovery and development of novel biologics for the … [Read more…]

Genexine to Present at H.C. Wainwright Global Investment Conference

SEOUL, South Korea–(BUSINESS WIRE)–Genexine (KOSDAQ: 095700), a publicly traded, clinical stage biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of unmet medical needs, today announced that Neil Warma, CEO of Genexine will be presenting virtually at the H.C. Wainwright Global Investment Conference being held on May 23-26, 2022. The … [Read more…]

IntelliCentrics’ Innovations Help Drive Advanced Dallas Hospital & Clinics’ Mission of Delivering Leading Edge Medicine and Personalized Patient Care

DALLAS–(BUSINESS WIRE)–IntelliCentrics (6819.HK) the innovator of the SEC³URE Ethos, SEC³URE Passport, Link & GO!, BioBytes™ and BioBytes™ Visitor, today announced Advanced Dallas Hospital & Clinics has joined IntelliCentrics’ SEC³URE Ethos, the largest healthcare community built on trust. IntelliCentrics is providing medical staff credentialing for its short-term acute care hospital physicians in Dallas. “We are extremely … [Read more…]

ASC Therapeutics Joins U.S. Consortium of Gene Therapy Partners Including the NIH and FDA to Accelerate Treatments for Rare Diseases

Public, private and non-profit organizations have joined forces to create a standardized approach that will reduce up-front costs and lower barriers to developing novel gene therapies for rare and ultra-rare diseases MILPITAS, Calif.–(BUSINESS WIRE)–ASC Therapeutics, a privately held biopharmaceutical company pioneering the development of transformative in-vivo gene replacement, gene editing and allogeneic cell therapies has … [Read more…]

Supplier J.M. Smucker Co.’s Jif Recall Prompts Fresh Del Monte to Voluntarily Recall Select Ready-To-Eat Products Due to Potential Salmonella Contamination

MIAMI–(BUSINESS WIRE)–J.M. Smucker Co.’s voluntary recall of select Jif® products in the United States has prompted Fresh Del Monte to voluntarily recall fresh-cut fruit and vegetable products containing ready-to-eat Jif® peanut butter dip due to the potential presence of Salmonella contamination. In response and out of an abundance of caution, Fresh Del Monte is recalling … [Read more…]

CORRECTING and REPLACING Press Ganey, KidsX to Launch Pediatric Healthcare Accelerator to Address Health Issues in Lives of Children

Now accepting applications from digital health startups interested in working alongside the nation’s leading children’s hospitals BOSTON–(BUSINESS WIRE)–In the release dated May 10, 2022, the sentence that was immediately preceding the bulleted item section should be removed. The updated release reads: PRESS GANEY, KIDSX TO LAUNCH PEDIATRIC HEALTHCARE ACCELERATOR TO ADDRESS HEALTH ISSUES IN LIVES … [Read more…]